Our Latest Posts
https://theranostics.sg/wp-content/uploads/2020/05/PSMA-Review.jpg
546
750
Dr Andrew Tan
https://theranostics.sg/wp-content/uploads/2020/01/Theranostics_logo-1-300x78.png
Dr Andrew Tan2020-03-30 04:06:012022-04-12 05:46:26PSMA Therapy Review
https://theranostics.sg/wp-content/uploads/2020/05/German.jpg
546
750
Dr Andrew Tan
https://theranostics.sg/wp-content/uploads/2020/01/Theranostics_logo-1-300x78.png
Dr Andrew Tan2020-03-30 04:04:412022-04-12 06:17:07PSMA German Multicenter Trial
https://theranostics.sg/wp-content/uploads/2020/05/Consensus-report-NET.jpg
546
750
Dr Andrew Tan
https://theranostics.sg/wp-content/uploads/2020/01/Theranostics_logo-1-300x78.png
Dr Andrew Tan2020-03-30 04:04:062022-04-12 15:01:56Consensus report on the treatment of Neuroendocrine Tumors
https://theranostics.sg/wp-content/uploads/2020/05/Lu177-phase-3.jpg
546
750
Dr Andrew Tan
https://theranostics.sg/wp-content/uploads/2020/01/Theranostics_logo-1-300x78.png
Dr Andrew Tan2020-03-30 03:14:102022-04-12 15:28:35Phase 3 trial using Lu177 Dotatate for midgut neuroendocrine tumors
https://theranostics.sg/wp-content/uploads/2020/05/Treatment-NET.jpg
546
750
Dr Andrew Tan
https://theranostics.sg/wp-content/uploads/2020/01/Theranostics_logo-1-300x78.png
Dr Andrew Tan2020-03-30 03:14:062022-04-14 06:57:38Treatment of Neuroendocrine Tumors with radiolabeled somatostatin analogues
https://theranostics.sg/wp-content/uploads/2020/05/Phase-2-PSMA.jpg
546
750
Dr Andrew Tan
https://theranostics.sg/wp-content/uploads/2020/01/Theranostics_logo-1-300x78.png
Dr Andrew Tan2020-03-30 03:13:592022-04-14 09:41:54Phase 2 trial evaluating Lu177 PSMA